A pair of new studies is shedding light on the complex relationship between hormones and attention-deficit/hyperactivity disorder (ADHD) in women, revealing that while hormonal fluctuations can significantly worsen ADHD symptoms, women with the condition may not necessarily report a more difficult menopause than their peers.
The research underscores a persistent issue: despite growing awareness, women with ADHD remain underdiagnosed, under-researched, and often lack treatment tailored to their unique hormonal needs across their lifespan.
Key Findings: ADHD Symptoms vs. Menopause Experience
A systematic review published in Frontiers in Global Women’s Health analyzed survey data from nearly 5,000 women and found that hormonal transitions—like those during puberty, pregnancy, and menopause—can exacerbate ADHD symptoms and mood disturbances.
This aligns with an ADDitude survey which found that 93% of women noticed a change in their ADHD symptom severity during perimenopause or menopause, and 63% said this period had the greatest impact on their lives of any stage.
However, a separate study in the Journal of Attention Disorders offers a surprising counterpoint. Researchers comparing 656 women with and without ADHD found that those with an ADHD diagnosis did not report experiencing worse menopausal symptoms (like hot flashes or night sweats) than women without ADHD.
The study suggested that women with ADHD might attribute concentration and memory problems to their existing condition rather than to menopause, potentially changing how they report symptoms. Despite this, ADHD symptoms were linked to a poorer overall quality of life during menopause.
Six Critical Gaps in Research on Women and ADHD
The Frontiers review identified six major areas where research is urgently needed to improve care for women with ADHD:
Executive Function: How fluctuating estrogen and progesterone levels across a woman’s life impact ADHD symptoms and brain function.
Puberty & Medication: How hormonal changes in adolescence affect ADHD symptoms and stimulant medication effectiveness.
Sexual Health: How ADHD influences risky sexual behaviors and how treatments could mitigate these risks.
Pregnancy & Postpartum: Understanding the heightened risks for postpartum depression and anxiety in mothers with
ADHD and identifying safe, effective treatments.
Gynecological Disorders: Investigating links between ADHD and conditions like PCOS, endometriosis, and PMDD.
Menopause & Aging: Research on how menopause and hormonal therapy affect ADHD symptoms and cognition, and why so many women are diagnosed later in life.
The Role of Medication
The Journal of Attention Disorders study found that current ADHD medications (both stimulant and non-stimulant) did not significantly alter a woman’s experience of menopausal symptoms. Researchers note that existing treatments may not be designed to address menopause-specific symptom changes and may need to be adjusted during this transition, alongside other forms of support.
The Bottom Line
While more research is critical, the message for healthcare providers and women is clear: hormonal milestones significantly impact ADHD. Women experiencing new or worsening focus, memory, or emotional regulation challenges during perimenopause should discuss their ADHD symptoms with a doctor, as they may be a key part of the menopausal transition that deserves specific attention and care.
YOU MAY ALSO LIKE
